The vector of anti-MART1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MART1. The T cells are genetically modified through transduction with a lentiviral vector expressing MART1-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C287||Lenti-MART-1 T cell receptor (RD1-MART-1 High) Viral Particle|
|VP-CAR-LC332||Lenti-MART-1(DMF5) CAR (scFv-CD28-FcεRIγ, Melan-A) Viral Particle|
|CAR-T-2-M310-2Z||Anti-MART-1(DMF5) scFv h(CD28-CD3ζ) CART, pCDCAR1|
|TCR-L252||Human anti-melan-A T cell receptor (SW-M1-29), pCDTCR1|
|VP-TCR-C305||Lenti-MART-1 T cell receptor (Cysteine-modiﬁed) Viral Particle|
|TCR-L254||Human anti-melan-A T cell receptor (SW-M1-66), pCDTCR1|
|TCR-C140Z||Human anti-MART1 T cell receptor (5), pCDTCR1|
|TCR-C136Z||Murinized anti-MART1 T cell receptor (RD1-MART1 High), pCDTCR1|
|TCR-L066Z||Murinized anti-MART-1 (ELAGIGILTV) T cell receptor, pCDTCR1|
|TCR-L069||Human anti-MLANA [27–35] T Cell Receptor, pLXSN|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved